Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy
Giuseppe Privitera, Daniela Pugliese, Sara Onali, Valentina Petito, Franco Scaldaferri, Antonio Gasbarrini, Silvio Danese, Alessandro Armuzzi
Topics & Concepts
MedicineVedolizumabInfliximabInflammatory bowel diseaseUlcerative colitisCombination therapyRegimenIntensive care medicineTargeted therapyDiseaseInternal medicineOncologyCancerInflammatory Bowel DiseaseLiver Diseases and ImmunityCeliac Disease Research and Management